Loading...
Population Pharmacokinetics of Perphenazine in Schizophrenia Patients from CATIE: Impact of Race and Smoking
The goal of the study was to characterize population pharmacokinetics (PPK) for perphenazine in patients with schizophrenia from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). Patients (n = 156) received 8–32 mg of perphenazine daily for 14 to 600 days for a total of 421 pl...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3648660/ https://ncbi.nlm.nih.gov/pubmed/19843655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0091270009343694 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|